Takeda Pharmaceutical Co Ltd

XHAM:TKD

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TKD's stock price target?

Price Target

33.96 EUR

According to Wall Street analysts, the average 1-year price target for TKD is 33.96 EUR with a low forecast of 28.24 EUR and a high forecast of 44.6 EUR.

What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?

Projected CAGR

2%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 4 years is 2%.

What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?

Projected CAGR

1%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 1%.

What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?

Projected CAGR

-5%

Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.

What is the Pre-Tax Income forecast for Takeda Pharmaceutical Co Ltd?

Projected CAGR

34%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 34%.

What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?

Projected CAGR

43%

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 43%.